期刊文献+

左西孟旦与多巴酚丁胺治疗急性失代偿心力衰竭患者的疗效比较 被引量:19

下载PDF
导出
摘要 急性失代偿性心力衰竭是心血管内科常见疾病。治疗的基本原则是减轻钠水潴留、减轻心脏前后负荷、增强心肌收缩力以缓解临床症状,提高生活质量。改善患者预后。临床上应用的传统的正性肌力药物(如地高辛、多巴酚丁胺、氨立农、米力农等)缺乏长期治疗降低病死率的证据,有些药物长期应用甚至增加病死率,
出处 《中国药物与临床》 CAS 2013年第2期237-239,共3页 Chinese Remedies & Clinics
  • 相关文献

参考文献6

二级参考文献40

  • 1Antoniades C, Tousoulis D, Koumallos N, et al. Levosimendan:beyond its simple inotropic effect in heart failure [J].Pharmacol Ther, 2007, 114 (2): 184-197.
  • 2Antila S, Sundbcrg S, Lehtonen LA. Clinical pharmacology of levosimendan [J].Clin Pharmacokinet, 2007, 46 (7): 535- 552.
  • 3Ikonomidis I, Parissis JT, Paraskevaidis I, et al. Effects of levosimendan on coronary artery flow and cardiac performance in patients with advanced heart failure [J]. Eur J Heart Fail, 2007, 9 (12): 1172-1177.
  • 4Parissis JT, Andreadou I, Bistola V, et al. Novel biologic mechanisms of levosimendan and its effect on the failing heart [J].Expert OpinInvestig Drugs, 2008, 17 (8): 1143-1150.
  • 5Parissis JT, Adamopoulos S, Antoniades C, et al. Effects of levosimendan on circulating pro inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure [J].Am J Cardiol, 2004, 93 (10):1309-1312.
  • 6Farmakis D, Parissis JT, Bistola V, et al. Plasma B-type natri uretic peptide reduction predicts long-term response to levosimendan therapy in acutely deeompensated chronic heart failure [J] Int J Cardiol, 2010, 139 (1): 75-79.
  • 7Tziakas DN, Chalikias GK, Hatzinikolaou HI, et al. Levosimendan use reduces matrix metalloproteinase-2 in patients with decompensated heart failure [J]. Cardiovasc Drugs Ther, 2005, 19 (6): 399-402.
  • 8Parissis JT, Andreadou I, Markantonis SL, et al. Effects of levosimendan on circulating markers of oxidative and nitrosative stress in patients with advanced heart failure [J]. Atherosclerosis, 2007, 195 (2): e210-e215.
  • 9Parissis JT, Karavidas A, Bistola V, et al. Effects of levosimendan on flow mediated vasodilation and soluble adhesion molecules in patients with advanced chronic heart failure [J]. Atherosclerosis, 2008, 197 (1): 278-282.
  • 10Lehtonen L, Poder P. The utility of levosimendan in the treatment of heart failure[J].Ann Med, 2007, 39 (1): 2-17.

共引文献49

同被引文献144

  • 1刘菊香,张杰.环磷腺苷葡胺与米力农治疗老年人心力衰竭疗效比较[J].中国临床医学,2005,12(1):21-22. 被引量:1
  • 2蒋宇,俞锐敏.急性失代偿性心力衰竭治疗进展[J].岭南急诊医学杂志,2009,14(6):501-503. 被引量:3
  • 3戴敏,杨俊华,徐苏丹,王惠芬,周炳元,赵彩明,宋建平.应用心衰超声指数评价舒张性心力衰竭的临床价值[J].中国实用内科杂志,2006,26(11):1706-1708. 被引量:23
  • 4ZIPESDP,LIBBYP,BONOWRO.心脏病学[M].陈灏珠,译.7版.北京:人民卫生出版社,2007:512-531.
  • 5HIGGINS J P T, GREEN S. Cochrane handbook for systematic reviews of interventions version 5. 1.0 [-updated Mareh 2011[M/OL]. The Coehrane Collaboration, 2011. http: //handbook. cochrane, org/.
  • 6KURT I H, YAVUZER K, BATUR M K. Short-term effect of levosimendan on free light chain kappa and lambda levels in patients with decompensated chronic heart failure[J]. Heart Vessels, 2010, 25(5) 392-399.
  • 7PARISSIS J T, PAPADOPOULOS C, NIKOLAOU M, et al. Effects of levosimendan on quality of life and emotional stress in advanced heart failure patients [J]. Cardiovase Drugs Ther, 2007, 21(4): 263-268.
  • 8KASIKCIOGLU H A, UNAL S, TARTAN Z, et al. Effects of levosimendan on left ventrieular functional remodelling and exercise intolerance: a tissue Doppler study [J]. J Int Med Res, 2005, 33(4): 397-405.
  • 9IKONOMIDIS I, PARISSIS J T, PARASKEVAIDIS I, et al. Effects of levosimendan on coronary artery flow and cardiac performance in patients with advanced heart failure [J]. Eur J Heart Fail, 2007, 9(12) : 1172-1177.
  • 10PARISSIS J T, ADAMOPOULOS S, FARMAKIS D, et al. Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure [J]. Heart, 2006, 92 (12) : 1768- 1772.

引证文献19

二级引证文献223

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部